WhatsAppWhatsAppBook Appointment
Oncology header art
99%
Oncology

Cancer treatment and infusion billing services for medical oncology practices.

Specialty highlight

99%

Built around payer rules, documentation requirements, and coding nuances.

Infusion Billing Accuracy

99%

Prior Auth Success Rate

97%

Overview

Billing in Oncology

A practical view of what makes this specialty unique.

Oncology billing is one of the most complex areas in healthcare, involving a combination of intensive E&M services for cancer management and a high volume of intricate infusion and injection services for chemotherapy and supportive care drugs. Our oncology billing service is designed for this complexity. We ensure accurate coding for all office visits, precise billing for chemotherapy and non-chemotherapy infusions, and meticulous management of the 340B program, prior authorizations, and oral oncolytic medications, maximizing your revenue and ensuring compliance.

Accurate coding for chemotherapy and biotherapy infusions.

Standardized into our workflow to reduce rework and protect revenue.

Expertise in billing for supportive care drugs (anti-emetics, growth factors, bisphosphonates).

Standardized into our workflow to reduce rework and protect revenue.

Management of hydration and prolonged infusion services.

Standardized into our workflow to reduce rework and protect revenue.

Coding for therapeutic apheresis and stem cell transplant services (if applicable).

Standardized into our workflow to reduce rework and protect revenue.

Challenges

What slows reimbursement

The common friction points that trigger delays, denials, and rework.

Key challenges
  • Accurately coding for chemotherapy and non-chemotherapy drug administration (infusion and injection).
  • Managing the complex prior authorization process for expensive oncology drugs.
  • Ensuring proper coding for oral oncolytics and other specialty pharmacy drugs.
  • Navigating the 340B drug pricing program and its reporting requirements.
  • Billing for prolonged infusions and managing hydration and supportive care services.
Our solutions
  • Certified oncology coders with deep expertise in medical oncology, hematology, and infusion services.
  • Precise coding for all levels of E&M services for established and new cancer patients.
  • Expertise in billing for chemotherapy administration (96401-96425) and non-chemotherapy infusions (96360-96379).
  • Meticulous management of drug coding using HCPCS J-codes and units.
  • Proactive prior authorization and re-authorization management for all oncology drugs.
  • Specialized support for 340B program compliance, reporting, and billing.
  • Detailed support for oral oncolytics and buy-and-bill medication management.
Features

Operational features that keep claims clean

Repeatable checks, payer alignment, and tight charge capture.

Accurate coding for chemotherapy and biotherapy infusions.

Included to improve first-pass acceptance and reduce downstream edits.

Expertise in billing for supportive care drugs (anti-emetics, growth factors, bisphosphonates).

Included to improve first-pass acceptance and reduce downstream edits.

Management of hydration and prolonged infusion services.

Included to improve first-pass acceptance and reduce downstream edits.

Coding for therapeutic apheresis and stem cell transplant services (if applicable).

Included to improve first-pass acceptance and reduce downstream edits.

Compliance with CMS and commercial payer rules for oncology drugs and administration.

Included to improve first-pass acceptance and reduce downstream edits.

Coding

Coding complexities we watch closely

Modifier usage, documentation rules, and specialty-specific payer edits.

Complexity checklist
  • Infusion coding based on the drug (chemotherapy vs. non-chemotherapy) and duration.
  • Correct coding for the drug product using J-codes and the exact number of units administered.
  • Billing for "incidenta" hydration and pre-medications alongside chemotherapy.
  • Coding for injection administration (e.g., 96372) vs. infusion.
Denial triggers

Missing prior authorization for chemotherapy drugs.

Incorrect coding of infusion time or units of drug.

Billing for drugs or supplies included in the administration code.

Lack of medical necessity documentation for specific regimens.

Incorrect J-code for the drug administered.

Codes

Common codes (examples)

Reference-only examples to illustrate the typical coding landscape.

CPT

96413 (Chemo Infusion, 1st hour), 96367 (IV Push, Additional), 99214 (Office Visit), 96401 (Chemo Injection), 96360 (Hydration)

ICD-10

C50.911 (Breast Cancer), C34.90 (Lung Cancer), C18.9 (Colon Cancer), C91.10 (CLL), D46.9 (MDS)

FAQ

Frequently Asked Questions

Got questions? We've got answers

Revenue cycle partners you can trust

Ready to transform your revenue cycle?

Join 500+ healthcare providers who've optimized collections, reduced denials, and gained predictable cash flow with MIMedCare. Get a free consultation and a tailored roadmap for your practice.

  • Dedicated account specialists for every specialty
  • Transparent KPIs with monthly performance reviews
  • HIPAA-ready workflows and secure reporting

Newsletter

Get billing insights weekly

Short, practical tips to improve collections and reduce denials.

One email per week. Unsubscribe anytime.

Media Library